Conestoga Capital Advisors LLC Trims Stake in National Research Corporation (NRCIB)
Conestoga Capital Advisors LLC cut its stake in shares of National Research Corporation (NASDAQ:NRCIB) by 1.6% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 213,285 shares of the business services provider’s stock after selling 3,525 shares during the quarter. Conestoga Capital Advisors LLC owned approximately 0.88% of National Research Corporation worth $11,532,000 at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the company. Cutler Group LP boosted its stake in shares of National Research Corporation by 95.0% during the second quarter. Cutler Group LP now owns 2,398 shares of the business services provider’s stock valued at $114,000 after purchasing an additional 1,168 shares in the last quarter. US Bancorp DE boosted its stake in shares of National Research Corporation by 178.4% during the second quarter. US Bancorp DE now owns 3,675 shares of the business services provider’s stock valued at $174,000 after purchasing an additional 2,355 shares in the last quarter. California Public Employees Retirement System bought a new position in shares of National Research Corporation during the second quarter valued at approximately $224,000. Tudor Investment Corp ET AL bought a new position in shares of National Research Corporation during the second quarter valued at approximately $243,000. Finally, Rice Hall James & Associates LLC boosted its stake in shares of National Research Corporation by 1.0% during the second quarter. Rice Hall James & Associates LLC now owns 10,102 shares of the business services provider’s stock valued at $480,000 after purchasing an additional 104 shares in the last quarter. 2.58% of the stock is currently owned by institutional investors and hedge funds.
The firm also recently announced a quarterly dividend, which was paid on Friday, October 13th. Investors of record on Friday, September 29th were paid a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 4.45%. The ex-dividend date of this dividend was Thursday, September 28th. National Research Corporation’s payout ratio is currently 461.55%.
TRADEMARK VIOLATION WARNING: This article was first reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are viewing this article on another site, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The correct version of this article can be viewed at https://theolympiareport.com/2017/11/02/conestoga-capital-advisors-llc-trims-stake-in-national-research-corporation-nrcib.html.
About National Research Corporation
National Research Corporation provides analytics and insights for the patient and employee experience in serving the healthcare providers, payers, and other healthcare organizations in the United States and Canada. Its portfolio of subscription-based solutions offer information and analysis services in a range of elements, including patient experience and satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement.
Want to see what other hedge funds are holding NRCIB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National Research Corporation (NASDAQ:NRCIB).
Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.